{"subsection_name": null, "pub_date": "2011-10-19T08:12:23Z", "byline": {"original": "By MICHAEL J. DE LA MERCED and BRUCE JAPSEN", "person": [{"firstname": "Michael", "middlename": "J.", "role": "reported", "lastname": "DE LA MERCED", "organization": "", "rank": 1}, {"lastname": "JAPSEN", "organization": "", "rank": 2, "role": "reported", "firstname": "Bruce"}]}, "abstract": "By breaking off its research pharmaceutical business, Abbott Laboratories will follow others that have turned to corporate breakups to bolster shareholder value.", "word_count": 704, "print_page": null, "news_desk": null, "snippet": "By breaking off its research pharmaceutical business, Abbott Laboratories will follow others that have turned to corporate breakups to bolster shareholder value.", "multimedia": [], "source": "The New York Times", "blog": [], "keywords": [{"name": "unknown", "value": "Abbott Laboratories|ABT|NYSE", "rank": "4"}, {"name": "organizations", "value": "Abbott Laboratories", "rank": "3"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "2"}, {"name": "type_of_material", "value": "News", "rank": "1"}], "type_of_material": "Blog", "lead_paragraph": "8:01 p.m. | Updated", "web_url": "http://dealbook.nytimes.com/2011/10/19/abbott-to-split-into-two/", "section_name": "Business Day", "headline": {"main": "Abbott Labs to Split Into 2 Companies", "kicker": "DealBook"}, "slideshow_credits": null, "_id": "4fd3a2088eb7c8105d8e96ff", "document_type": "blogpost"}